rs2227583

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_002658.6(PLAU):​c.1119+62T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00829 in 1,488,076 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0078 ( 16 hom., cov: 32)
Exomes 𝑓: 0.0083 ( 98 hom. )

Consequence

PLAU
NM_002658.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.558

Publications

1 publications found
Variant links:
Genes affected
PLAU (HGNC:9052): (plasminogen activator, urokinase) This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
C10orf55 (HGNC:31008): (chromosome 10 putative open reading frame 55) Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00778 (1185/152260) while in subpopulation SAS AF = 0.0237 (114/4810). AF 95% confidence interval is 0.0202. There are 16 homozygotes in GnomAd4. There are 556 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1185 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLAUNM_002658.6 linkc.1119+62T>C intron_variant Intron 10 of 10 ENST00000372764.4 NP_002649.2 P00749-1A0A024QZM9Q59GZ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLAUENST00000372764.4 linkc.1119+62T>C intron_variant Intron 10 of 10 1 NM_002658.6 ENSP00000361850.3 P00749-1

Frequencies

GnomAD3 genomes
AF:
0.00782
AC:
1189
AN:
152142
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00786
Gnomad ASJ
AF:
0.0181
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0239
Gnomad FIN
AF:
0.00471
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.0107
Gnomad OTH
AF:
0.0129
GnomAD4 exome
AF:
0.00835
AC:
11152
AN:
1335816
Hom.:
98
AF XY:
0.00916
AC XY:
6033
AN XY:
658266
show subpopulations
African (AFR)
AF:
0.00150
AC:
45
AN:
29926
American (AMR)
AF:
0.00684
AC:
218
AN:
31892
Ashkenazi Jewish (ASJ)
AF:
0.0183
AC:
378
AN:
20622
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38322
South Asian (SAS)
AF:
0.0279
AC:
1984
AN:
71122
European-Finnish (FIN)
AF:
0.00681
AC:
339
AN:
49794
Middle Eastern (MID)
AF:
0.0422
AC:
156
AN:
3700
European-Non Finnish (NFE)
AF:
0.00719
AC:
7442
AN:
1035316
Other (OTH)
AF:
0.0107
AC:
590
AN:
55122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
524
1047
1571
2094
2618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00778
AC:
1185
AN:
152260
Hom.:
16
Cov.:
32
AF XY:
0.00747
AC XY:
556
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00168
AC:
70
AN:
41546
American (AMR)
AF:
0.00778
AC:
119
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0181
AC:
63
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.0237
AC:
114
AN:
4810
European-Finnish (FIN)
AF:
0.00471
AC:
50
AN:
10620
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0107
AC:
725
AN:
68022
Other (OTH)
AF:
0.0128
AC:
27
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
59
119
178
238
297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00588
Hom.:
4
Bravo
AF:
0.00694
Asia WGS
AF:
0.0100
AC:
37
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.7
DANN
Benign
0.76
PhyloP100
-0.56
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227583; hg19: chr10-75675219; API